A citation-based method for searching scientific literature

Andrew D Krystal, Diego A Pizzagalli, Moria Smoski, Sanjay J Mathew, John Nurnberger, Sarah H Lisanby, Dan Iosifescu, James W Murrough, Hongqiu Yang, Richard D Weiner, Joseph R Calabrese, Gerard Sanacora, Gretchen Hermes, Richard S E Keefe, Allen Song, Wayne Goodman, Steven T Szabo, Alexis E Whitton, Keming Gao, William Z Potter. Nat Med 2020
Times Cited: 23







List of co-cited articles
114 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.
William A Carlezon, Andrew D Krystal. Depress Anxiety 2016
59
26

The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development.
Andrew D Krystal, Diego A Pizzagalli, Sanjay J Mathew, Gerard Sanacora, Richard Keefe, Allen Song, Joseph Calabrese, Andrew Goddard, Wayne Goodman, Sarah H Lisanby,[...]. Nat Rev Drug Discov 2018
23
21

Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects.
Stephen L Lowe, Conrad J Wong, Jennifer Witcher, Celedon R Gonzales, Gemma L Dickinson, Robert L Bell, Linda Rorick-Kehn, MaryAnn Weller, Randall R Stoltz, Jane Royalty,[...]. J Clin Pharmacol 2014
52
21

Assessing anhedonia in depression: Potentials and pitfalls.
Sakina J Rizvi, Diego A Pizzagalli, Beth A Sproule, Sidney H Kennedy. Neurosci Biobehav Rev 2016
117
17

Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.
Thomas Insel, Bruce Cuthbert, Marjorie Garvey, Robert Heinssen, Daniel S Pine, Kevin Quinn, Charles Sanislow, Philip Wang. Am J Psychiatry 2010
17

The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
Benjamin B Land, Michael R Bruchas, Julia C Lemos, Mei Xu, Erica J Melief, Charles Chavkin. J Neurosci 2008
370
17

Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders.
Moriah L Jacobson, Caroline A Browne, Irwin Lucki. Annu Rev Pharmacol Toxicol 2020
11
36

LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
Linda M Rorick-Kehn, Jeffrey M Witkin, Michael A Statnick, Elizabeth L Eberle, Jamie H McKinzie, Steven D Kahl, Beth M Forster, Conrad J Wong, Xia Li, Robert S Crile,[...]. Neuropharmacology 2014
82
17

Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS).
Diego A Pizzagalli, Moria Smoski, Yuen-Siang Ang, Alexis E Whitton, Gerard Sanacora, Sanjay J Mathew, John Nurnberger, Sarah H Lisanby, Dan V Iosifescu, James W Murrough,[...]. Neuropsychopharmacology 2020
4
100


Reward Processing in Depression: A Conceptual and Meta-Analytic Review Across fMRI and EEG Studies.
Hanna Keren, Georgia O'Callaghan, Pablo Vidal-Ribas, George A Buzzell, Melissa A Brotman, Ellen Leibenluft, Pedro M Pan, Liana Meffert, Ariela Kaiser, Selina Wolke,[...]. Am J Psychiatry 2018
78
13

Evaluation of opioid modulation in major depressive disorder.
Elliot Ehrich, Ryan Turncliff, Yangchun Du, Richard Leigh-Pemberton, Emilio Fernandez, Reese Jones, Maurizio Fava. Neuropsychopharmacology 2015
91
13

Blunted reward responsiveness in remitted depression.
Pia Pechtel, Sunny J Dutra, Elena L Goetz, Diego A Pizzagalli. J Psychiatr Res 2013
87
13

FMRI visualization of brain activity during a monetary incentive delay task.
B Knutson, A Westdorp, E Kaiser, D Hommer. Neuroimage 2000
692
13

Reconsidering anhedonia in depression: lessons from translational neuroscience.
Michael T Treadway, David H Zald. Neurosci Biobehav Rev 2011
636
13

Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors.
Edgardo Falcon, Caroline A Browne, Rosa M Leon, Vanessa C Fleites, Rachel Sweeney, Lynn G Kirby, Irwin Lucki. Neuropsychopharmacology 2016
59
13

Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats.
William A Carlezon, Cécile Béguin, Jennifer A DiNieri, Michael H Baumann, Michele R Richards, Mark S Todtenkopf, Richard B Rothman, Zhongze Ma, David Y-W Lee, Bruce M Cohen. J Pharmacol Exp Ther 2006
259
13

Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging.
Ming-Qiang Zheng, Nabeel Nabulsi, Su Jin Kim, Giampaolo Tomasi, Shu-Fei Lin, Charles Mitch, Steven Quimby, Vanessa Barth, Karen Rash, John Masters,[...]. J Nucl Med 2013
51
13

A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.
R P Snaith, M Hamilton, S Morley, A Humayan, D Hargreaves, P Trigwell. Br J Psychiatry 1995
613
13

Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats.
John W Muschamp, Ashlee Van't Veer, Aram Parsegian, Miranda S Gallo, Melissa Chen, Rachael L Neve, Edward G Meloni, William A Carlezon. J Neurosci 2011
75
13

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
13

Identification of short-acting κ-opioid receptor antagonists with anxiolytic-like activity.
Matthew F Peters, Anna Zacco, John Gordon, Carla M Maciag, Linda C Litwin, Carolann Thompson, Patricia Schroeder, Linda A Sygowski, Timothy M Piser, Todd A Brugel. Eur J Pharmacol 2011
37
13

Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase.
Michael R Bruchas, Tao Yang, Selena Schreiber, Mia Defino, Steven C Kwan, Shuang Li, Charles Chavkin. J Biol Chem 2007
119
13

Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity.
Thomas A Munro, Loren M Berry, Ashlee Van't Veer, Cécile Béguin, F Ivy Carroll, Zhiyang Zhao, William A Carlezon, Bruce M Cohen. BMC Pharmacol 2012
55
13

Receptor Occupancy of the κ-Opioid Antagonist LY2456302 Measured with Positron Emission Tomography and the Novel Radiotracer 11C-LY2795050.
Mika Naganawa, Gemma L Dickinson, Ming-Qiang Zheng, Shannan Henry, Francois Vandenhende, Jennifer Witcher, Robert Bell, Nabeel Nabulsi, Shu-Fei Lin, Jim Ropchan,[...]. J Pharmacol Exp Ther 2016
27
13

Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
Allison T Knoll, Edward G Meloni, James B Thomas, F Ivy Carroll, William A Carlezon. J Pharmacol Exp Ther 2007
172
13

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.
R Uher, R H Perlis, N Henigsberg, A Zobel, M Rietschel, O Mors, J Hauser, M Z Dernovsek, D Souery, M Bajs,[...]. Psychol Med 2012
160
8

The neural correlates of anhedonia in major depressive disorder.
Paul A Keedwell, Chris Andrew, Steven C R Williams, Mick J Brammer, Mary L Phillips. Biol Psychiatry 2005
399
8

Lack of ventral striatal response to positive stimuli in depressed versus normal subjects.
Jane Epstein, Hong Pan, James H Kocsis, Yihong Yang, Tracy Butler, Jesse Chusid, Hilary Hochberg, James Murrough, Erika Strohmayer, Emily Stern,[...]. Am J Psychiatry 2006
270
8

Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder.
Diego A Pizzagalli, Avram J Holmes, Daniel G Dillon, Elena L Goetz, Jeffrey L Birk, Ryan Bogdan, Darin D Dougherty, Dan V Iosifescu, Scott L Rauch, Maurizio Fava. Am J Psychiatry 2009
633
8

The effects of psychotherapy on neural responses to rewards in major depression.
Gabriel S Dichter, Jennifer N Felder, Christopher Petty, Joshua Bizzell, Monique Ernst, Moria J Smoski. Biol Psychiatry 2009
148
8

Neural responses to monetary incentives in major depression.
Brian Knutson, Jamil P Bhanji, Rebecca E Cooney, Lauren Y Atlas, Ian H Gotlib. Biol Psychiatry 2008
307
8

Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior.
Emily A Ferenczi, Kelly A Zalocusky, Conor Liston, Logan Grosenick, Melissa R Warden, Debha Amatya, Kiefer Katovich, Hershel Mehta, Brian Patenaude, Charu Ramakrishnan,[...]. Science 2016
238
8


The Brain's Response to Reward Anticipation and Depression in Adolescence: Dimensionality, Specificity, and Longitudinal Predictions in a Community-Based Sample.
Argyris Stringaris, Pablo Vidal-Ribas Belil, Eric Artiges, Hervé Lemaitre, Fanny Gollier-Briant, Selina Wolke, Hélène Vulser, Ruben Miranda, Jani Penttilä, Maren Struve,[...]. Am J Psychiatry 2015
98
8

Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults.
Jordan F Karp, Meryl A Butters, Amy E Begley, Mark D Miller, Eric J Lenze, Daniel M Blumberger, Benoit H Mulsant, Charles F Reynolds. J Clin Psychiatry 2014
98
8

Impaired reward prediction error encoding and striatal-midbrain connectivity in depression.
Poornima Kumar, Franziska Goer, Laura Murray, Daniel G Dillon, Miranda L Beltzer, Andrew L Cohen, Nancy H Brooks, Diego A Pizzagalli. Neuropsychopharmacology 2018
46
8


Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders.
Claudia Hägele, Florian Schlagenhauf, Michael Rapp, Philipp Sterzer, Anne Beck, Felix Bermpohl, Meline Stoy, Andreas Ströhle, Hans-Ulrich Wittchen, Raymond J Dolan,[...]. Psychopharmacology (Berl) 2015
100
8

Neural representation of reward in recovered depressed patients.
Ciara McCabe, Philip J Cowen, Catherine J Harmer. Psychopharmacology (Berl) 2009
164
8

Reward processing dysfunction in major depression, bipolar disorder and schizophrenia.
Alexis E Whitton, Michael T Treadway, Diego A Pizzagalli. Curr Opin Psychiatry 2015
283
8

Reduced reward learning predicts outcome in major depressive disorder.
Elske Vrieze, Diego A Pizzagalli, Koen Demyttenaere, Titia Hompes, Pascal Sienaert, Peter de Boer, Mark Schmidt, Stephan Claes. Biol Psychiatry 2013
171
8

Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder.
Erika E Forbes, Ahmad R Hariri, Samantha L Martin, Jennifer S Silk, Donna L Moyles, Patrick M Fisher, Sarah M Brown, Neal D Ryan, Boris Birmaher, David A Axelson,[...]. Am J Psychiatry 2009
347
8

Neuroscience of apathy and anhedonia: a transdiagnostic approach.
Masud Husain, Jonathan P Roiser. Nat Rev Neurosci 2018
75
8

Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.
Ciara McCabe, Zevic Mishor, Philip J Cowen, Catherine J Harmer. Biol Psychiatry 2010
179
8



Neural reward processing in individuals remitted from major depression.
B Ubl, C Kuehner, P Kirsch, M Ruttorf, H Flor, C Diener. Psychol Med 2015
14
14

Association of Neural and Emotional Impacts of Reward Prediction Errors With Major Depression.
Robb B Rutledge, Michael Moutoussis, Peter Smittenaar, Peter Zeidman, Tanja Taylor, Louise Hrynkiewicz, Jordan Lam, Nikolina Skandali, Jenifer Z Siegel, Olga T Ousdal,[...]. JAMA Psychiatry 2017
50
8

The mesolimbic dopamine reward circuit in depression.
Eric J Nestler, William A Carlezon. Biol Psychiatry 2006
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.